Bixi Tang
Shanghai, 200031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Design, Synthesis, and Anti-Hepatic Fibrosis Evaluation of Cordycepin Derivatives.
Journal: Molecules (Basel, Switzerland)
Published: December 09, 2025
Bariatric surgery resolves MASH by enhancing MAT1A-dependent one-carbon metabolism.
Journal: Nature communications
Published: October 22, 2025
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases.
Journal: Nature
Published: July 20, 2025
DNA-Encoded Noncanonical Substrate Library for Protease Profiling.
Journal: Chembiochem : a European journal of chemical biology
Published: June 27, 2024
Exploratory research on the effective chemical basis of tanreqing injection for treating acute lung injury: In vivo, in vitro and in silico.
Journal: Journal of ethnopharmacology
Published: June 18, 2024
A novel pectin-like polysaccharide from Crocus sativus targets Galectin-3 to inhibit hepatic stellate cells activation and liver fibrosis.
Journal: Carbohydrate polymers
Published: April 15, 2024
Inulin-like polysaccharide ABWW may impede CCl4 induced hepatic stellate cell activation through mediating the FAK/PI3K/AKT signaling pathway in vitro & in vivo.
Journal: Carbohydrate polymers
Published: August 26, 2023
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
Journal: Protein & cell
Published: April 07, 2022
Discovery of 4-cyclopropyl-3-(2-((1-cyclopropyl-1H-pyrazol-4-yl) amino) quinazolin-6-yl)-N-(3-(trifluoromethyl) phenyl) benzamides as potent discoidin domain receptor inhibitors for the treatment of idiopathic pulmonary fibrosis.
Journal: Acta pharmaceutica Sinica. B
Published: July 28, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026